|Articles|July 1, 2003
- LCGC North America-07-01-2003
- Volume 21
- Issue 7
Validation of Impurity Methods, Part I
This column is the first installment in a two-part series reviewing ICH and FDA impurity method validation guidelines.
Advertisement
Articles in this issue
over 22 years ago
Why Do Peaks Tail?over 22 years ago
Analysis of Various Cyanobacterial Toxins by LC–MSover 22 years ago
ASTM Subcommittee E13.19 on ChromatographyNewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Advancing RNA-Based Therapeutics: IQ Consortium Experts on Optimizing Chromatographic Bioanalysis
5
